Answers are grounded in this paper and cite their sources.
Narrative review suggests GLP-1 receptor agonists improve pre-operative weight loss in hernia repair, indicating potential benefits for patient outcomes.
There may be a promising role for GLP-1 receptor agonists in the neoadjuvant approach to abdominal wall hernia repair, by inducing and accelerating pre-operative weight loss without a negative impact on post-operative outcomes. Only limited conclusions can yet be drawn at this stage and large-scale prospective studies, ideally in a randomized controlled setting, are necessary to investigate this finding further.
No takes yet. Share an insight, caveat, or question.
Prabhakaran et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: